Medicinal Plant Research 2025, Vol.15, No.3, 129-141 http://hortherbpublisher.com/index.php/mpr 140 Nam O., Kim J., Kang S., Chae Y., Jih M., You H., Koh J., and Kim Y., 2024, Ginsenoside Rb1 alleviates lipopolysaccharide‐induced inflammation in human dental pulp cells via the PI3K/Akt, NF‐κB, and MAPK signalling pathways, International Endodontic Journal, 57(6): 759-768. https://doi.org/10.1111/iej.14058 Niu Z., Liu Y., Zhou D., Feng J., Hu Y., He Z., Shen T., Piao J., Wu H., and Hu W., 2025, Ginsenoside F2 from the leaves of Panax ginseng alleviates DSS-induced ulcerative colitis: An in silico analysis and in vivo investigation, Industrial Crops and Products, 225: 120458. https://doi.org/10.1016/j.indcrop.2025.120458 Paik S., Song G.Y., and Jo E.K., 2023, Ginsenosides for therapeutically targeting inflammation through modulation of oxidative stress, International Immunopharmacology, 121: 110461. https://doi.org/10.1016/j.intimp.2023.110461 Pan S., Peng L., Yi Q., Qi W., Yang H., Wang H., and Wang L., 2024, Ginsenoside Rh2 alleviates LPS-induced inflammatory responses by binding to TLR4/MD-2 and blocking TLR4 dimerization, International Journal of Molecular Sciences, 25(17): 9546. https://doi.org/10.3390/ijms25179546 Park J.D., 2024, Metabolism and drug interactions of Korean ginseng based on the pharmacokinetic properties of ginsenosides: Current status and future perspectives, Journal of Ginseng Research, 48(3): 253-265. https://doi.org/10.1016/j.jgr.2024.02.003 Qian J., Jiang Y., and Hu H., 2024, Ginsenosides: an immunomodulator for the treatment of colorectal cancer, Frontiers in Pharmacology, 15: 1408993. https://doi.org/10.3389/fphar.2024.1408993 Qu Q., Zhang W., Xuan Z., Chen R., Huang Y., Hu Y., Lin Y., Liu M., Lv W., and Guo S., 2025, Evaluation of anti-inflammatory effects of six ginsenosides and Rg1 regulation of macrophage polarization and metabolites to alleviate colitis, Antioxidants, 14(3): 283. https://doi.org/10.3390/antiox14030283 Ratan Z.A., Haidere M.F., Hong Y.H., Park S.H., Lee J.O., Lee J., and Cho J.Y., 2021, Pharmacological potential of ginseng and its major component ginsenosides, Journal of Ginseng Research, 45(2): 199-210. https://doi.org/10.1016/j.jgr.2020.02.004 Sharma A., and Lee H.J., 2020, Ginsenoside compound K: Insights into recent studies on pharmacokinetics and health-promoting activities, Biomolecules, 10(7): 1028. https://doi.org/10.3390/biom10071028 Shi Y., Wang H., Zheng M., Xu W., Yang Y., and Shi F., 2020, Ginsenoside Rg3 suppresses the NLRP3 inflammasome activation through inhibition of its assembly, The FASEB Journal, 34(1): 208-221. https://doi.org/10.1096/fj.201901537R Shi Z., Chen H., Zhou X., Yang W., and Lin Y., 2022, Pharmacological effects of natural medicine ginsenosides against Alzheimer’s disease, Frontiers in Pharmacology, 13: 952332. https://doi.org/10.3389/fphar.2022.952332 Sun M., Ji Y., Li Z., Chen R., Zhou S., Liu C., and Du M., 2020, Ginsenoside Rb3 inhibits pro-inflammatory cytokines via MAPK/AKT/NF-κB pathways and attenuates rat alveolar bone resorption in response to porphyromonas gingivalis LPS, Molecules, 25(20): 4815. https://doi.org/10.3390/molecules25204815 Tang P., Liu S., Zhang J., Ai Z., Hu Y., Cui L., Zou H., Li X., Wang Y., Nan B., and Wang Y., 2024, Ginsenosides as dietary supplements with immunomodulatory effects: a review, Applied Biological Chemistry, 67(1): 27. https://doi.org/10.1186/s13765-024-00881-y To K.I., Zhu Z.X., Wang Y.N., Li G.A., Sun Y.M., Li Y., and Jin Y.H., 2022, Integrative network pharmacology and experimental verification to reveal the anti-inflammatory mechanism of ginsenoside Rh4, Frontiers in Pharmacology, 13: 953871. https://doi.org/10.3389/fphar.2022.953871 Wang J., Zeng L., Zhang Y., Qi W., Wang Z., Tian L., Zhao D., Wu Q., Li X., and Wang T., 2022, Pharmacological properties, molecular mechanisms and therapeutic potential of ginsenoside Rg3 as an antioxidant and anti-inflammatory agent, Frontiers in Pharmacology, 13: 975784. https://doi.org/10.3389/fphar.2022.975784 Wang Y., Zhang Y., Chi X., Ma X., Xu W., Shi F., and Hu S., 2019, Anti-inflammatory mechanism of ginsenoside Rg1: Proteomic analysis of milk from goats with mastitis induced with lipopolysaccharide, International Immunopharmacology, 71: 382-391. https://doi.org/10.1016/j.intimp.2019.03.048 Won H., Kim H., Park T., Kim H., Jo K., Jeon H., Ha S., Hyun J., Jeong A., Kim J., Park Y., Eo Y., and Lee J., 2019, Non-clinical pharmacokinetic behavior of ginsenosides, Journal of Ginseng Research, 43(3): 354-360. https://doi.org/10.1016/j.jgr.2018.06.001 Xu H., Liu M., Chen G., Wu Y., Xie L., Han X., Zhang G., Tan Z., Ding W., Fan H., Chen H., Liu B., and Zhou Y., 2022, Anti-inflammatory effects of ginsenoside Rb3 in LPS-induced macrophages through direct inhibition of TLR4 signaling pathway, Frontiers in Pharmacology, 13: 714554. https://doi.org/10.3389/fphar.2022.714554 Yang J., Li S., Wang L., Du F., Zhou X., Song Q., Zhao J., and Fang R., 2018, Ginsenoside Rg3 attenuates lipopolysaccharide-induced acute lung injury via MerTK-dependent activation of the PI3K/AKT/mTOR pathway, Frontiers in Pharmacology, 9: 850. https://doi.org/10.3389/fphar.2018.00850
RkJQdWJsaXNoZXIy MjQ4ODYzNA==